0001123292-24-000107.txt : 20240412 0001123292-24-000107.hdr.sgml : 20240412 20240412161829 ACCESSION NUMBER: 0001123292-24-000107 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240412 DATE AS OF CHANGE: 20240412 EFFECTIVENESS DATE: 20240412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VACCINEX, INC. CENTRAL INDEX KEY: 0001205922 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 161603202 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-510533 FILM NUMBER: 24841730 BUSINESS ADDRESS: STREET 1: 1895 MOUNT HOPE AVE CITY: ROCHESTER STATE: NY ZIP: 14620 BUSINESS PHONE: 585-271-2700 MAIL ADDRESS: STREET 1: 1895 MOUNT HOPE AVE CITY: ROCHESTER STATE: NY ZIP: 14620 FORMER COMPANY: FORMER CONFORMED NAME: VACCINEX INC DATE OF NAME CHANGE: 20021114 D 1 primary_doc.xml X0708 D LIVE 0001205922 VACCINEX, INC. 1895 Mount Hope Avenue Rochester NY NEW YORK 14620 585-271-2700 DELAWARE None VACCINEX INC Corporation true Chrystyna Bedrij Stecyk 1895 Mount Hope Avenue Rochester NY NEW YORK 14620 Director Elizabeth Evans 1895 Mount Hope Avenue Rochester NY NEW YORK 14620 Executive Officer Jill Sanchez 1895 Mount Hope Avenue Rochester NY NEW YORK 14620 Executive Officer Maurice Zauderer, Ph.D. 1895 Mount Hope Avenue Rochester NY NEW YORK 14620 Director Executive Officer Barbara Yanni 1895 Mount Hope Avenue Rochester NY NEW YORK 14620 Director Gerald E. Van Strydonck 1895 Mount Hope Avenue Rochester NY NEW YORK 14620 Director Bala S. Manian, Ph.D. 1895 Mount Hope Avenue Rochester NY NEW YORK 14620 Director Jacob B. Frieberg 1865 Mount Hope Avenue Rochester NY NEW YORK 14620 Director Albert D. Friedberg 1865 Mount Hope Avenue Rochester NY NEW YORK 14620 Director Ernest S. Smith, Ph.D. 1865 Mount Hope Avenue Rochester NY NEW YORK 14620 Executive Officer Pharmaceuticals $1 - $1,000,000 06b false 2024-03-29 false true true true false 0 3499995 1750000 1749995 Total remaining to be sold represents the aggregate exercise price of warrants to purchase shares of the Company's common stock. false 1 0 0 0 Vaccinex, Inc. /s/ Maurice Zauderer Maurice Zauderer, Ph.D. President, CEO 2024-04-12